Home > News & reports > News > Dominion Post: Malaghan Institute coming for leukaemia with purpose-built immunotherapy labs

Dominion Post: Malaghan Institute coming for leukaemia with purpose-built immunotherapy labs

1 May 2018

Disclaimer: no CAR-T cell trial is open at present. When the trial does open, we will inform clinicians who work with the relevant group of patients for recruitment. Patients or those interested need to first talk with their doctor about their treatment options, including trial options.